CHOLESTYRAMINE IN TYPE-II HYPERLIPOPROTEINEMIA - DOUBLE-BLIND TRIAL

被引：117

作者：

LEVY, RI ^{[1
]}

FREDRICKSON, DS ^{[1
]}

STONE, NJ ^{[1
]}

BILHEIMER, DW ^{[1
]}

BROWN, WV ^{[1
]}

GLUECK, CJ ^{[1
]}

GOTTO, AM ^{[1
]}

HERBERT, PN ^{[1
]}

KWITEROVICH, PO ^{[1
]}

LANGER, T ^{[1
]}

LAROSA, J ^{[1
]}

LUX, SE ^{[1
]}

RIDER, AK ^{[1
]}

SHULMAN, RS ^{[1
]}

SLOAN, HR ^{[1
]}

机构：

[1] NHLI, MOLEC DIS BRANCH, BETHESDA, MD 20014 USA

来源：

ANNALS OF INTERNAL MEDICINE | 1973年 / 79卷 / 01期

关键词：

D O I：

10.7326/0003-4819-79-1-51

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：51 / 58

页数：8

共 50 条

[41] FAMILIAL TYPE-II HYPERLIPOPROTEINEMIA IN A CHINESE FAMILY [J].

KHOO, KL ;

CHONG, YH ;

PILLAY, RP .

MEDICAL JOURNAL OF AUSTRALIA, 1973, 1 (21) :1048-1050

[42] EFFECT OF EXERCISE TRAINING IN TYPE-II HYPERLIPOPROTEINEMIA [J].

MELISH, J ;

BRONSTEIN, D ;

GROSS, R ;

DANN, D ;

WHITE, J ;

HUNT, H ;

BROWN, WV .

CIRCULATION, 1978, 58 (04) :38-38

[43] EFFECT OF LOVASTATIN ON HEMORHEOLOGY IN TYPE-II HYPERLIPOPROTEINEMIA [J].

KOPPENSTEINER, R ;

MINAR, E ;

EHRINGER, H .

ATHEROSCLEROSIS, 1990, 83 (01) :53-58

[44] DETERMINANTS OF BLOOD RHEOLOGY IN TYPE-II HYPERLIPOPROTEINEMIA [J].

LOWE, GDO ;

DRUMMOND, MM ;

STROMBERG, P ;

LORIMER, AR ;

FORBES, CD .

SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1981, 41 :263-263

[45] RESULTS OF COLESTIPOL THERAPY IN TYPE-II HYPERLIPOPROTEINEMIA [J].

LEES, AM ;

MCCLUSKEY, MA ;

LEES, RS .

ATHEROSCLEROSIS, 1976, 24 (1-2) :129-140

[46] BEZAFIBRATE AND FENOFIBRATE IN TYPE-II DIABETICS WITH HYPERLIPOPROTEINEMIA [J].

SMUD, R ;

SERMUKSLIS, B .

CURRENT MEDICAL RESEARCH AND OPINION, 1987, 10 (09) :612-624

[47] 2 FAMILIES OF TYPE-II HYPERLIPOPROTEINEMIA WITH XANTHOMA [J].

ISHIMOTO, S ;

MIMURA, G ;

KIMURA, T ;

KAJIHARA, K .

JAPANESE JOURNAL OF HUMAN GENETICS, 1975, 20 (01) :41-42

[48] COLESTIPOL AND CHOLESTYRAMINE RESIN - COMPARATIVE EFFECTS IN FAMILIAL TYPE II HYPERLIPOPROTEINEMIA [J].

GLUECK, CJ ;

FORD, S ;

STEINER, P ;

SCHEEL, D .

JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1972, 222 (06) :676-&

[49] EFFICACY AND SAFETY OF SIMVASTATIN (ALONE OR IN ASSOCIATION WITH CHOLESTYRAMINE) - A 1-YEAR STUDY IN 66 PATIENTS WITH TYPE-II HYPERLIPOPROTEINEMIA [J].

EMMERICH, J ;

AUBERT, I ;

BAUDUCEAU, B ;

DACHET, C ;

CHANU, B ;

ERLICH, D ;

GAUTIER, D ;

JACOTOT, B ;

ROUFFY, J .

EUROPEAN HEART JOURNAL, 1990, 11 (02) :149-155

[50] PRAVASTATIN AND CHOLESTYRAMINE EFFECTS ON LP(A) IN TYPE-II HYPERLIPIDEMIA [J].

CORDER, CN ;

YE, SQ ;

BARBI, G ;

MCCONATHY, WJ .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1990, 47 (02) :204-204

← 1 2 3 4 5 →